I am currently an ML Scientist at Nosis Bio. Our mission is to end all chronic disease.
I completed my PhD at MIT in the Kulik Group, where I worked on ML-guided chemical discovery. My PhD research was supported by the NSF, DARPA, and
the Office of Naval Research.
Personal Information
-
Ph.D. (MIT) 2023; B.S. (Caltech) 2018
Teaching
- Fall, 2020, 10.585: Engineering Nanotechnology (TA)
- Spring, 2018, ChE 105: Dynamics and
Control of Chemical Systems (TA)
- Winter, 2018, ChE 103b: Transport
Phenomena (TA)
- Fall, 2017, ChE 15: Introduction to
Chemical Engineering Computation (TA)
- Spring, 2017, ACM 95b/100b: Applied
and Computational Mathematics (TA)
- Fall, 2016, ChE 62: Separation
Processes (TA)
- Winter, 2016, Ch1b: General
Chemistry (TA)
Research
I am interested in advancing AI- and ML-accelerated virtual screening of novel therapeutics, whereby safe
and effective medicines are rapidly
discovered on demand for any disease.
I have worked on several areas in the design of novel matter, including:
- Mathematically calculating the properties of novel molecules using GPUs
- Database [web] of
>100k molecules and their properties
- Inferring trends and design principles from chemical data [web]
- Accelerating design by using machine learning to calculate chemical properties in milliseconds (rather
than
hours, in the case of GPU calculations) [pdf]
- Reducing the number of GPU calculations needed to train machine learning models [web, web]
- Helping humans interactively co-create new molecules with trained ML models
- MolSimplify Lite [web] - design tool for transition metal
complexes
- MOFSimplify [web, pdf] - design tool for
metal-organic frameworks
- Helping humans guide state-of-the-art AI model architectures (transformers), which are used in
molecular design [web]
|